| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 1.50 | 0.00 (0.00%) | 1.50 - 3.51 | 660.8 thousand (Below Avg) |
Market data as of 4:00PM 05/17/13. Quotes are delayed by at least 15 min.
| Open | 1.51 |
|---|---|
| Previous Close | 1.50 |
| Day's Range | 1.50 - 1.54 |
| Market Cap | 65.6M |
| Avg Volume (10 Day) | 748.3K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -0.91 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Fail |
| Borrows within reasonable limits? | Fail |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
Discovery Labs Announces Completion of $14.25 Million Public Offering
PR Newswire - Wednesday 05/15/2013 10:45 AM ET
Discovery Labs Prices $14.25 Million Public Offering of Common Stock
PR Newswire - Friday 05/10/2013 8:45 AM ET
Discovery Labs Announces Proposed Public Offering of Common Stock
PR Newswire - Thursday 05/09/2013 4:01 PM ET
Discovery Labs Reports First Quarter 2013 Financial Results
PR Newswire - Tuesday 05/07/2013 7:45 AM ET
| DSCO | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 32.84% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | 0.66 | |
| LT Debt/Equity | 0.66 | |
| Earnings Yield | -- | |
| Price/Sales | 245.87 |
| Company | Last | Change |
|---|---|---|
| 6.75 | -7.66% | |
| Lpath Inc | 4.99 | +0.81% |
| Synthetic Biologics Inc | 1.42 | -1.39% |
| Oramed Pharmaceuticals Inc | 8.60 | +1.30% |
| MediciNova Inc | 3.54 | +4.42% |
Data is delayed by at least 15 min.